Dr. Mary-Claire King was the first to demonstrate that a single gene on chromosome 17q21 (then named BRCA1) was responsible for breast and ovarian cancer in many families in the 1990s, thus demonstrating a heredity component in these cancers and proving that gene mutations could predict vulnerability to these diseases [12]. The gene discussed is BRCA1; the disease is ovarian cancer.